|
A comparative study of gellan gum and xanthan gum versus commercial vehicles as pharmaceutical thickening agents in oral suspensions
Pauline Claraz
,
Luc Fillaudeau
,
Chloé Jadoul
,
Thomas Storme
,
Coralie Guillemot
et al.
Article dans une revue
hal-04875081
v1
|
|
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care
Benoit Blanchet
,
Alexandre Xu-Vuilard
,
Anne Jouinot
,
Florent Puisset
,
David Combarel
et al.
Article dans une revue
hal-04920549
v1
|
|
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care
Benoit Blanchet
,
Alexandre Xu-Vuilard
,
Anne Jouinot
,
Florent Puisset
,
David Combarel
et al.
Article dans une revue
hal-04972253
v1
|
|
Exposure toxicity of venetoclax in acute myeloid leukemia patients in the real-life setting: impact of high exposure on delayed neutropenia
Florent Puisset
,
Emmanuel Raffoux
,
Lionel Ades
,
Tony Huynh
,
Raphaël Itzykson
et al.
Article dans une revue
hal-04920565
v1
|
|
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care
Benoit Blanchet
,
Alexandre Xu-Vuilard
,
Anne Jouinot
,
Florent Puisset
,
David Combarel
et al.
Article dans une revue
hal-04821736
v1
|
|
Attributes for a discrete-choice experiment on preferences of patients for oncology pharmacy consultations
Margaux Damerval
,
Mohammed Bennani
,
Catherine Rioufol
,
Selim Omrani
,
Margaux Riboulet
et al.
Article dans une revue
hal-04826152
v1
|
|
Investigating the clinical impact of dose‐banding for weekly paclitaxel in patients with breast cancer: A retrospective and monocentric study
Florent Puisset
,
Félicien Le Louedec
,
Florence Dalenc
,
Lorène Verguet
,
Eleonora de Maio
et al.
Article dans une revue
hal-04920299
v1
|
|
Investigating the clinical impact of dose‐banding for weekly paclitaxel in patients with breast cancer: A retrospective and monocentric study
Florent Puisset
,
Félicien Le Louedec
,
Florence Dalenc
,
Lorène Verguet
,
Eleonora de Maio
et al.
Article dans une revue
hal-04972257
v1
|
|
Considering the Oral Bioavailability of Protein Kinase Inhibitors: Essential in Assessing the Extent of Drug–Drug Interaction and Improving Clinical Practice
Félicien Le Louedec
,
Florent Puisset
,
Etienne Chatelut
,
Michel Tod
Article dans une revue
hal-04973559
v1
|
|
Infectious risk when prescribing rituximab in patients with hypogammaglobulinemia acquired in the setting of autoimmune diseases
Xavier Boumaza
,
Margaux Lafaurie
,
Emmanuel Treiner
,
Ondine Walter
,
Gregory Pugnet
et al.
Article dans une revue
hal-04972256
v1
|
|
Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cancer
Florent Puisset
,
Mourad Mseddi
,
Loïc Mourey
,
Damien Pouessel
,
Benoit Blanchet
et al.
Article dans une revue
hal-04973562
v1
|
|
Retrospective, real‐life study of venetoclax plus azacitidine or low‐dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy
Louise Laloi
,
Natacha Chaumard Billotey
,
Pierre-Yves Dumas
,
Franciane Paul
,
Alban Villate
et al.
Article dans une revue
hal-04972259
v1
|
|
Easy and reliable maximum a posteriori Bayesian estimation of pharmacokinetic parameters with the open‐source R package mapbayr
Félicien Le Louedec
,
Florent Puisset
,
Fabienne Thomas
,
Étienne Chatelut
,
Mélanie White-Koning
Article dans une revue
hal-04821229
v1
|
|
Life-threatening complications after high-dose methotrexate and the benefits of glucarpidase as salvage therapy: a cohort study of 468 patients
Chloé Medrano
,
Lucie Obéric
,
Florent Puisset
,
Christian Récher
,
Delphine Larrieu-Ciron
et al.
Article dans une revue
inserm-04791818
v1
|
|
Limited Sampling Strategy for Determination of Ibrutinib Plasma Exposure: Joint Analyses with Metabolite Data
Félicien Le Louedec
,
Fanny Gallais
,
Fabienne Thomas
,
Mélanie White-Koning
,
Ben Allal
et al.
Article dans une revue
inserm-04791320
v1
|
|
Easy and reliable maximum a posteriori Bayesian estimation of pharmacokinetic parameters with the open‐source R package mapbayr
Félicien Le Louedec
,
Florent Puisset
,
Fabienne Thomas
,
Étienne Chatelut
,
Mélanie White-Koning
Article dans une revue
hal-04972260
v1
|
|
Severe toxicity of capecitabine in a patient with DPD deficiency after a safe FEC-100 experience: why we should test DPD deficiency in all patients before high-dose fluoropyrimidines
Maud Maillard
,
Audrey Eche-Gass
,
Mony Ung
,
Aurélie Brice
,
Sabrina Marsili
et al.
Article dans une revue
hal-04972262
v1
|
|
Body Surface Area Dosing of High-Dose Methotrexate Should Be Reconsidered, Particularly in Overweight, Adult Patients
Fanny Gallais
,
Lucie Oberic
,
Stanislas Faguer
,
Suzanne Tavitian
,
Thierry Lafont
et al.
Article dans une revue
hal-04973414
v1
|
|
Involvement of Pazopanib and Sunitinib Aldehyde Reactive Metabolites in Toxicity and Drug–Drug Interactions in Vitro and in Patient Samples
Marie-Noelle Paludetto
,
Jean-Luc Stigliani
,
Anne Robert
,
Vania Bernardes-Génisson
,
Etienne Chatelut
et al.
Article dans une revue
hal-02448694
v1
|
|
Formulae recently proposed to estimate renal glomerular filtration rate improve the prediction of carboplatin clearance
Mélanie White-Koning
,
Marie Noëlle Paludetto
,
Félicien Le Louedec
,
Laurence Gladieff
,
Christine Chevreau
et al.
Article dans une revue
hal-04920331
v1
|
|
Brentuximab vedotin in real life, a seven year experience in patients with refractory/relapsed CD30+ T cell lymphoma
Lucie Oberic
,
Faustine Delzor
,
Caroline Protin
,
Sophie Perriat
,
Camille Laurent
et al.
Article dans une revue
hal-04920640
v1
|
|
Assessment of efficacy of postinfusion tubing flushing in reducing risk of cytotoxic contamination
Pauline Claraz
,
Isabelle Riff
,
Charlotte Vert
,
Elina Wolff
,
Sophie Perriat
et al.
Article dans une revue
hal-04920636
v1
|
|
Association between clinically relevant toxicities of pazopanib and sunitinib and the use of weak CYP3A4 and P-gp inhibitors
Camille Azam
,
Pauline Claraz
,
Christine Chevreau
,
Camille Vinson
,
Ewa Cottura
et al.
Article dans une revue
hal-04973416
v1
|
|
Life-threatening complications after high-dose methotrexate and the benefits of glucarpidase as salvage therapy: a cohort study of 468 patients
Chloé Medrano
,
Lucie Oberic
,
Florent Puisset
,
Christian Recher
,
Delphine Larrieu-Ciron
et al.
Article dans une revue
hal-04972263
v1
|
|
Formulae recently proposed to estimate renal glomerular filtration rate improve the prediction of carboplatin clearance
Melanie White-Koning
,
Marie Noëlle Paludetto
,
Félicien Le Louedec
,
Laurence Gladieff
,
Christine Chevreau
et al.
Article dans une revue
hal-04973418
v1
|
|
Involvement of Pazopanib and Sunitinib Aldehyde Reactive Metabolites in Toxicity and Drug–Drug Interactions in Vitro and in Patient Samples
Marie-Noëlle Paludetto
,
Jean-Luc Stigliani
,
Anne Robert
,
Vania Bernardes-Génisson
,
Etienne Chatelut
et al.
Article dans une revue
hal-04973511
v1
|
|
Identifying the reactive metabolites of tyrosine kinase inhibitors in a comprehensive approach: Implications for drug‐drug interactions and hepatotoxicity
Marie-Noëlle Paludetto
,
Florent Puisset
,
Etienne Chatelut
,
Cécile Arellano
,
Marie‐noëlle Paludetto
Article dans une revue
hal-04973564
v1
|
|
The prognostic impact of immune-related adverse events during anti-PD1 treatment in melanoma and non–small-cell lung cancer: a real-life retrospective study
R. Dupont
,
E. Bérard
,
F. Puisset
,
T. Comont
,
J.-P. Delord
et al.
Article dans une revue
hal-04973507
v1
|
|
Simultaneous monitoring of pazopanib and its metabolites by UPLC–MS/MS
Marie-Noëlle Paludetto
,
Florent Puisset
,
Félicien Le Louedec
,
Ben Allal
,
Thierry Lafont
et al.
Article dans une revue
hal-04970346
v1
|
|
Metalloporphyrin-Catalyzed Oxidation of Sunitinib and Pazopanib, Two Anticancer Tyrosine Kinase Inhibitors: Evidence for New Potentially Toxic Metabolites
Marie-Noëlle Paludetto
,
Christian Bijani
,
Florent Puisset
,
Vania Bernardes-Génisson
,
Cécile Arellano
et al.
Article dans une revue
hal-04973547
v1
|
|
Metalloporphyrin-catalyzed oxidation of sunitinib and pazopanib, two anticancer tyrosine kinase inhibitors: Evidence for new potentially toxic metabolites
Marie-Noëlle Paludetto
,
Christian Bijani
,
Florent Puisset
,
Vania Bernardes-Génisson
,
C. Arellano
et al.
Article dans une revue
hal-01952871
v1
|
|
Safety of oral hydration after cisplatin infusion in an outpatient lung cancer unit
Florent Puisset
,
Laurence Bigay-Game
,
Marie Noëlle Paludetto
,
Audrey Martel
,
Sophie Perriat
et al.
Article dans une revue
hal-04970347
v1
|
|
Standardization of chemotherapy and individual dosing of platinum compounds.
Florent Puisset
,
Antonin Schmitt
,
Etienne Chatelut
Anticancer Research, 2014, 34 (1), pp.465-70
Article dans une revue
hal-04970342
v1
|
|
The Scientific Basis of Body Surface Area–Based Dosing
E Chatelut
,
F Puisset
Article dans une revue
hal-04970344
v1
|
|
Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody‐mediated disease
Florent Puisset
,
Mélanie White-Koning
,
Nassim Kamar
,
Antoine Huart
,
Frédérique Haberer
et al.
Article dans une revue
hal-04970340
v1
|
|
Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents
E Chatelut
,
M White-Koning
,
R Hj Mathijssen
,
F Puisset
,
S Baker
et al.
Article dans une revue
hal-04970339
v1
|
|
Clinical pharmacodynamic factors in docetaxel toxicity
F Puisset
,
J Alexandre
,
J-M Treluyer
,
V Raoul
,
H Roché
et al.
Article dans une revue
hal-04970337
v1
|
|
Dexamethasone as a probe for CYP3A4 metabolism: evidence of gender effect
F. Puisset
,
E. Chatelut
,
A. Sparreboom
,
J.-P. Delord
,
D. Berchery
et al.
Article dans une revue
hal-04970336
v1
|
|
Dexamethasone as a probe for vinorelbine clearance
Florent Puisset
,
Florence Dalenc
,
Etienne Chatelut
,
Thierry Cresteil
,
Isabelle Lochon
et al.
Article dans une revue
hal-04970324
v1
|
|
Dexamethasone as a probe for docetaxel clearance
Florent Puisset
,
Etienne Chatelut
,
Florence Dalenc
,
Florent Busi
,
Thierry Cresteil
et al.
Article dans une revue
hal-04970323
v1
|